PolyTears datasheet 20131027 - Medsafe
NAME AND ADDRESS OF THE SPONSOR Ioquin (A Division of Alcon Laboratories (Australia) Pty Ltd) 25 Frenchs Forest Road East FRENCHS FOREST NSW 2086
Download PolyTears datasheet 20131027 - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Wave Category Donor Item 2016 Item Description ...
wellingtonpta.org2016 Eat, Drink & Bid Merry - Auction Item List Item # Wave Category Donor Item 2016 Item Description Restrictions Fair Market Value 1 Silver Entertainment
Pedestrian Slip Resistance testing to AS/NZS …
www.equus.co.nzCentral Laboratories Report 10-527919.85 Pedestrian Slip Resistance testing to AS/NZS 3661.1: 1993 for Equus. S.M. Potter September 2010 …
Operational Guideline: Design and Construction of …
www.foodsafety.govt.nzTe Pou Oranga Kai O Aotearoa Operational Guideline: Design and Construction of Dairy Premises and Equipment 13 April 2006 New Zealand Food Safety Authority
NATIONAL FORAGE TESTING ASSOCIATION PO …
www.foragetesting.orgPhone: 402-416-0052 Email: nfta@foragetesting.org Fax: 831-303-4938 Website: www.foragetesting.org NATIONAL FORAGE TESTING ASSOCIATION PO Box 1470
IDC
www.idc-online.comIDC TeChnologIes IDC Technologies was founded in 1992. Since then, we have built a strong reputation globally as a provider of practical, technical training.
SECTION 25 BUSINESS DISTRICT COMMERCIAL …
www.london.caSECTION 25 . BUSINESS DISTRICT COMMERCIAL (BDC) ZONE . 25.1 GENERAL PURPOSE OF THE BDC ZONE This Zone is normally intended to implement the Main Street Commercial Corridor
MYDRIACYL Eye Drops - Medsafe
www.medsafe.govt.nzInternal document code Myd110418cNZ PAGE: 1 MYDRIACYL TM Eye Drops Tropicamide Ophthalmic Solution 0.5% & 1.0% CONSUMER MEDICINE INFORMATION